Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2022-03-09

Clinical Trial Update: Role of the Gut Microbiota in Pediatric Epilepsy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial exploring how gut microbiota affects pediatric epilepsy in drug-resistant cases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: British Columbia Children's Hospital | Conditions: Drug Resistant Epilepsy | Phase 4 | Status: UNKNOWN